More needs to be done to treat kala-azar

Health Principal Secretary Nicholas Muraguri. FILE PHOTO | BILLY MUTAI | NATION MEDIA GROUP

What you need to know:

  • Eastern Africa is the most affected in Africa, with an estimated 29,000 to 56,000 cases every year.
  • The most significant achievement is that the therapy is cheaper and has nearly halved the length of treatment from the previous 30 to 17 days.
  • Although this is good news, the reality on the ground is that many patients still do not have access to this treatment. Internationally, gaps exist due to market failure.

Visceral leishmaniasis, commonly known as kala-azar, is the most deadly parasitic disease after malaria.

Welcome!

You're all set to enjoy unlimited Prime content.